Vraylar (cariprazine) has an unusually long half-life compared to most psychiatric medications. The parent drug itself has a half-life of 2 to 4 days, but the story doesn’t end there. Your body converts Vraylar into active metabolites that keep working long after you take each capsule, and the most important one has a half-life of roughly 1 to 3 weeks. This makes Vraylar one of the longest-acting oral medications in psychiatry.
The Three Active Compounds in Your System
When you take Vraylar, your liver breaks it down primarily through the CYP3A4 enzyme into two active metabolites. These aren’t waste products. They bind to the same receptors as the original drug and contribute directly to how Vraylar works. The three compounds and their half-lives are:
- Cariprazine (the parent drug): 2 to 4 days
- DCAR (first metabolite): 1 to 2 days
- DDCAR (second metabolite): 1 to 3 weeks
DDCAR is the one that matters most. The FDA’s clinical pharmacology review identifies it as “the main contributor to the clinical effectiveness and safety” of Vraylar. After weeks of daily dosing, DDCAR builds up to concentrations far higher than cariprazine itself, and it lingers in your body long after each dose. In clinical studies with daily dosing, DDCAR’s measured half-life ranged from about 200 to 400 hours (roughly 8 to 17 days), depending on the dose and study duration.
Why Steady State Takes So Long
Most medications reach a stable level in your bloodstream within a few days. Vraylar is different. Because DDCAR accumulates slowly, reaching steady state can take weeks. The FDA prescribing information notes that for some patients, DDCAR hadn’t even reached steady state by the end of a 12-week treatment period.
This matters for how quickly the drug starts working at full strength. When your prescriber increases your dose, the full effect of that change won’t show up in your blood levels for several weeks. The same is true in reverse: if your dose is lowered, the higher levels take weeks to fully clear.
How Long Vraylar Stays After You Stop
After your last dose, the total active drug concentration (cariprazine plus its metabolites) drops by about 50% in roughly one week. But because DDCAR has such a long half-life, a full washout takes much longer. It generally takes 5 to 10 weeks for Vraylar and its metabolites to fully clear your system after discontinuation. For some people, it can take even longer.
This extended presence has a practical upside: missing a single dose of Vraylar is far less disruptive than missing a dose of a shorter-acting medication. Your active drug levels barely dip. But it also means that if you experience a side effect, it won’t resolve quickly just because you stopped taking the capsule. The drug is still active in your body for weeks afterward.
What the Long Half-Life Means for Side Effects
The most important practical consequence of Vraylar’s half-life is that side effects can appear weeks after you start taking it, not just in the first few days. Because DDCAR keeps accumulating over time, the FDA warns that “adverse events may first appear several weeks after the initiation of VRAYLAR treatment.” This includes movement-related side effects like restlessness (akathisia) and muscle stiffness.
Short-term clinical trials may actually underestimate side effect rates for this reason. Someone who feels fine during the first two weeks of treatment could develop new symptoms in week four or five as DDCAR levels continue to rise. The FDA recommends monitoring for adverse reactions for several weeks after starting Vraylar and after each dose change, not just in the days immediately following.
If you do develop side effects and stop the medication, those symptoms may also take weeks to fade. The decline in plasma levels “may not be immediately reflected in patients’ clinical symptoms,” as the prescribing information states.
Interactions That Extend the Half-Life Further
Because Vraylar is primarily broken down by the CYP3A4 liver enzyme, anything that inhibits this enzyme will slow the metabolism of cariprazine and increase the concentration of its active metabolites. If you start taking a strong CYP3A4 inhibitor (certain antifungal or antibiotic medications, for example), the standard guidance is to cut the Vraylar dose in half. The CYP2D6 enzyme also plays a smaller role in metabolism, so medications that block this enzyme can have a similar, though less pronounced, effect.